Testicular Histology after Treatment with the new Antiandrogen Casodex for Carcinoma of the Prostate
- 1 March 1994
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Urology and Nephrology
- Vol. 28 (1) , 67-70
- https://doi.org/10.3109/00365599409180473
Abstract
Five men aged 55-78 years, had received Casodex 50 mg p.o. daily for seven to 12 months. Because of tumour progression orchiectomy was performed. All testes were examined with light- and electronmicroscopy. Evidence of Leydig cell hyperplasia was present in testes from three patients. However, the ultrastructural appearance of the Leydig cells was normal. The spermatogenesis was reduced in all testes, although not significantly different from controls. We believe the Leydig cell hyperplasia reflects an increased proliferative stimulation by luteinizing hormone or a direct effect of Casodex.Keywords
This publication has 2 references indexed in Scilit:
- Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg DoseJournal of Clinical Endocrinology & Metabolism, 1975
- Action of a Nonsteroidal Antiandrogen, Flutamide, on the Receptor Binding and Nuclear Retention of 5α-Dihydrotestosterone in Rat Ventral Prostate1Endocrinology, 1974